Effect of melatonin on diabetes

Effect of melatonin on serum glucose level in patiets with type 2 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016010520219N2

Enrollment

Registered

2016-03-13

Start date

2016-04-03

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: intervention: melatonin 6 mg. Intervention 2: control : placebo.

Treatment - Drugs

intervention: melatonin 6 mg

control : placebo

Eligibility

Sex/Gender

All

Age

25 Years to 65 Years

Inclusion criteria

Inclusion criteria: inclusion criteria : type 2 diabetes; FBS less than 250 exclusion criteria : renal failure; hepatic failure; epilepsy; pregnancy; breast feeding; warfarin consumption; psychotic disease

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose. Timepoint: before and after intervention. Method of measurement: laboratory measurement (mg/dl).	—

Secondary

Measure	Time frame
Serum lipids. Timepoint: before and three months after intervention. Method of measurement: laboratory (mg/dl).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhgan Afkhamizadeh

Mashad University of Medical Sciences

afkhamizadehm@mums.ac.ir+98 51 3859 8818

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026